A Quality-of-Life Comparison of Two Fecal Incontinence Phenotypes: Isolated Fecal Incontinence Versus Concurrent Fecal Incontinence With Constipation.


Journal

Diseases of the colon and rectum
ISSN: 1530-0358
Titre abrégé: Dis Colon Rectum
Pays: United States
ID NLM: 0372764

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 20 11 2018
medline: 12 3 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

Many patients with fecal incontinence report coexisting constipation. This subset of patients has not been well characterized or understood. The purpose of this study was to report the frequency of fecal incontinence with concurrent constipation and to compare quality-of-life outcomes of patients with fecal incontinence with and without constipation. This was a prospective cohort study. Survey data, including Fecal Incontinence Severity Index, Constipation Severity Instrument, Fecal Incontinence Quality of Life survey (categorized as lifestyle, coping, depression, and embarrassment), Pelvic Organ Prolapse Inventory and Urinary Distress Inventory surveys, and anorectal physiology testing were obtained. The study was conducted as a single-institution study from January 2007 to January 2017. Study patients had fecal incontinence presented to a tertiary pelvic floor center. Quality-of-life survey findings were measured. A total of 946 patients with fecal incontinence were identified, and 656 (69.3%) had coexisting constipation. Patients with fecal incontinence with constipation were less likely to report a history of pregnancy (89.2% vs 91.4%; p = 0.001) or complicated delivery, such as requiring instrumentation (9.1% vs 18.1%; p = 0.005), when compared with patients with isolated fecal incontinence. Patients with fecal incontinence with constipation had higher rates of coexisting pelvic organ prolapse (Pelvic Organ Prolapse Inventory: 18.4 vs 8.2; p < 0.01), higher rates of urinary incontinence (Urinary Distress Inventory: 30.2 vs 23.4; p = 0.01), and higher pressure findings on manometry; intussusception on defecography was common. Patients with fecal incontinence with concurrent constipation had less severe incontinence scores at presentation (21.0 vs 23.8; p < 0.001) and yet lower overall health satisfaction (28.9% vs 42.5%; p < 0.001). Quality-of-life scores declined as constipation severity increased for lifestyle, coping, depression, and embarrassment. This was a single-institution study, and surgeon preference could bias population and anorectal physiology testing. Patients with fecal incontinence with concurrent constipation represent a different disease phenotype and have different clinical and anorectal physiology test findings and worse overall quality of life. Treatment of these patients requires careful consideration of prolapse pathology with coordinated treatment of coexisting disorders. See Video Abstract at http://links.lww.com/DCR/A783.

Sections du résumé

BACKGROUND
Many patients with fecal incontinence report coexisting constipation. This subset of patients has not been well characterized or understood.
OBJECTIVE
The purpose of this study was to report the frequency of fecal incontinence with concurrent constipation and to compare quality-of-life outcomes of patients with fecal incontinence with and without constipation.
DESIGN
This was a prospective cohort study. Survey data, including Fecal Incontinence Severity Index, Constipation Severity Instrument, Fecal Incontinence Quality of Life survey (categorized as lifestyle, coping, depression, and embarrassment), Pelvic Organ Prolapse Inventory and Urinary Distress Inventory surveys, and anorectal physiology testing were obtained.
SETTINGS
The study was conducted as a single-institution study from January 2007 to January 2017.
PATIENTS
Study patients had fecal incontinence presented to a tertiary pelvic floor center.
MAIN OUTCOME MEASURES
Quality-of-life survey findings were measured.
RESULTS
A total of 946 patients with fecal incontinence were identified, and 656 (69.3%) had coexisting constipation. Patients with fecal incontinence with constipation were less likely to report a history of pregnancy (89.2% vs 91.4%; p = 0.001) or complicated delivery, such as requiring instrumentation (9.1% vs 18.1%; p = 0.005), when compared with patients with isolated fecal incontinence. Patients with fecal incontinence with constipation had higher rates of coexisting pelvic organ prolapse (Pelvic Organ Prolapse Inventory: 18.4 vs 8.2; p < 0.01), higher rates of urinary incontinence (Urinary Distress Inventory: 30.2 vs 23.4; p = 0.01), and higher pressure findings on manometry; intussusception on defecography was common. Patients with fecal incontinence with concurrent constipation had less severe incontinence scores at presentation (21.0 vs 23.8; p < 0.001) and yet lower overall health satisfaction (28.9% vs 42.5%; p < 0.001). Quality-of-life scores declined as constipation severity increased for lifestyle, coping, depression, and embarrassment.
LIMITATIONS
This was a single-institution study, and surgeon preference could bias population and anorectal physiology testing.
CONCLUSIONS
Patients with fecal incontinence with concurrent constipation represent a different disease phenotype and have different clinical and anorectal physiology test findings and worse overall quality of life. Treatment of these patients requires careful consideration of prolapse pathology with coordinated treatment of coexisting disorders. See Video Abstract at http://links.lww.com/DCR/A783.

Identifiants

pubmed: 30451749
doi: 10.1097/DCR.0000000000001242
doi:

Types de publication

Clinical Trial Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-70

Auteurs

Christy E Cauley (CE)

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Lieba R Savitt (LR)

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Milena Weinstein (M)

Department of Gynecology, Massachusetts General Hospital, Boston, Massachusetts.

May M Wakamatsu (MM)

Department of Gynecology, Massachusetts General Hospital, Boston, Massachusetts.

Hiroko Kunitake (H)

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Rocco Ricciardi (R)

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Kyle Staller (K)

Department of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts.

Liliana Bordeianou (L)

Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH